IKJ Capital — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Portal Biotechnologiesportal.bio in 𝕏May 2026

Portal develops a universal cell engineering platform designed to expand the biological potential of cell therapies and improve their accessibility for research and therapeutic applications.

BiotechDeep TechHealthtechArlington, US

Armon Sharei(Executive Officer, Director)in

Co-investorsScaleGood Fund LP (powered by TELUS)Undeterred Capital IA Ventures NFX Pear VC TechU Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.